Results 151 to 160 of about 15,149 (207)
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment. [PDF]
Malar JLaird VR, Plucinski MM, Venkatesan M, Rondini KA, Randrianarivelojosia M, Andriamananjara MN, Moonga H, Ishengoma DS, Chidimatembue A, Dimbu PR, Adeothy AL, Beavogui AH, Kariuki S, Nsobya SL, Uwimana A, Kahunu GM, Assefa A, Koita OA, Lucchi NW, Souza SSS, Zhou Z, Moriarty LF, Halsey ES. +22 moreeuropepmc +1 more sourceGlobal medium-term research priority setting for seasonal malaria chemoprevention: results from an eDelphi study. [PDF]
BMJ Glob HealthRichardson S, Steele A, Scott S, Ainsworth J, Eckert E, Tchouatieu AM, Sillah JS, Cuomo-Dannenburg G, Okereke E, Okeh DU, Tonks S, Ndiaye JL, Dentinger C, Rassi C, Baker K. +14 moreeuropepmc +1 more sourceMOESM2 of Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
, 2018 Elizabeth Davlantes, Pedro Rafael Dimbu, Carolina Miguel Ferreira, Maria Florinda João, Dilunvuidi Pode, Jacinto Félix, Edgar Sanhangala, Benjamin Nieto Andrade, Samaly S. Svigel Souza, Eldin Talundzic, Venkatachalam Udhayakumar, Chantelle Owens, Eliane Mbounga, Lubbe Wiesner, Eric S. Halsey, José Franco Martins, Marcos Fraga Fortes, Mateusz M. Pluciński +17 moreopenalex +1 more sourceEffect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.
Lancet Glob HealthSuresh J, Zimmermann M, Maiteki C, Stahlfeld A, Pratt A, Mathanga DP, Staedke SG, Laufer MK, Drakeley C, Bever C, Cohee LM. +10 moreeuropepmc +1 more source